Constantine Farmakidis, MD

Articles by Constantine Farmakidis, MD

A Closer Look at Nipocalimab’s Impact on Myasthenia Gravis Care: Constantine Farmakidis, MD

ByMaggie L. Shaw,Constantine Farmakidis, MD

July 3rd 2025

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved patient outcomes across diverse populations.

Latest Updated Articles

Constantine Farmakidis, MD

Articles by Constantine Farmakidis, MD

A Closer Look at Nipocalimab’s Impact on Myasthenia Gravis Care: Constantine Farmakidis, MD

Latest Updated Articles

Trending on AJMC

Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo

FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis

Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS

FDA Grants Breakthrough Therapy Designation to R-DXd in CDH6-Expressing Ovarian Cancer

Evaluating Current Breast Cancer Care, Treatments: Lakshminarayanan Nandagopal, MD